Evolving evidence on the association between COVID-19 and overweight/obesity/abdominal obesity requires a new urgency for action. The existence of many ‘obesity phenotypes’ has recently emerged, with different grades of association with CVD risk, according to physical and lifestyle aspects. This may also reflect the existence of different phenotypes and grades of COVID-19 severity among obese individuals. Obesity, which is much more ‘pandemic’ than COVID-19, has not received prioritization, which is rising fastest in emerging economies. It is a gateway to many other non-communicable diseases and mental-health illnesses, and is now a major factor in COVID-19 severity, risk of complications and mortality. There is a window of opportunity to advocate for fund and implement these actions in all countries to ensure better, more resilient, and sustainable health for all now and in our post-COVID-19 future.
|Titolo:||Does abdominal obesity influence immunological response to SARS-CoV-2 infection?|
|Data di pubblicazione:||Being printed|
|Appare nelle tipologie:||01.01 Articolo in Rivista|